Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004457
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
1999-10-18
Brief Title:
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
Sponsor:
National Institute of Neurological Disorders and Stroke NINDS
Organization:
Office of Rare Diseases ORD
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2001-01
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVES
I Determine specific clinical features molecular abnormalities and laboratory-based biological markers of free radical stress that are associated with amyotrophic lateral sclerosis and influence disease severity
I Determine specific clinical features molecular abnormalities and laboratory-based biological markers of free radical stress that are associated with amyotrophic lateral sclerosis and influence disease severity
Detailed Description:
PROTOCOL OUTLINE This is a screening and diagnostic study Blood and urine samples are collected from patients every 2 months for 1 year All samples are evaluated for measures of free radical damage and levels of the bodys own antioxidant activity
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MGH-97-7231 | None | None | None |
| MGH-1K08NS01896 | None | None | None |